Structured evidence table for Berberine Pcos Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Berberine Pcos Meta-Analysis | Importantly, PCOS is strongly associated with significant metabolic disturbances, such as insulin resistance (IR) and dyslipidemia, which elevate the long-term risk for type 2 diabetes and cardiovascular morbidity [,]. | 3 | Liu Siqi (2026) | Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives |
| Berberine Pcos Meta-Analysis | Metformin improves metabolic parameters as an insulin sensitizer [], but its use is limited by gastrointestinal side effects, variable efficacy, and insufficient evidence as a monotherapy on the core reproductive features like ovulation and hirsutism []. | 3 | Liu Siqi (2026) | Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives |
| Berberine Pcos Meta-Analysis | Preclinical and clinical studies indicate that natural products such as quercetin, resveratrol, berberine, curcumin, and rutin can exert pleiotropic effects, including enhanced insulin sensitivity, reduced oxidative stress, mitigated chronic inflammation, and modulated hormonal activity. | 3 | Liu Siqi (2026) | Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives |
| Berberine Pcos Meta-Analysis | 1 2 3 4 5 6 7 Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine–metabolic disorders, affecting approximately 5–18% of reproductive-aged women worldwide []. | 3 | Liu Siqi (2026) | Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives |
| Berberine Pcos Meta-Analysis | Editorial: A lifecourse perspective on polycystic ovary syndrome (PCOS): bridging gaps in research and practice. | 4 | Joshi A (2026) | Editorial: A lifecourse perspective on polycystic ovary syndrome (PCOS): bridging gaps in research and practice. |
Source documents